Dr. Kleem Chaudhary is Head of Business Development & Licensing for MS, AD, OPN, and Platforms at Biogen in Cambridge, MA. He has over 15 years of experience within the biotech and large pharma industry with broad experience across business development and licensing as well as in strategy and basic drug discovery. Prior to joining Biogen, Dr. Chaudhary was in business development at Takeda focused on gastroenterology and oncology transactions. He began his business development career and spent almost a decade at Novartis, where he was a transactions leader and led business development activities across multiple therapeutic areas. Prior to Novartis, he worked as a medicinal chemistry lab head at Gilead Sciences. Dr. Chaudhary holds a Ph.D. in chemistry from the University of North Carolina at Chapel Hill and a B.Sc. in chemistry from the University of Winnipeg.